Viatris este un partener dedicat în domeniul Oftalmologiei și suntem încântați să susținem Ziua Mondială a Vederii prin organizarea unui webinar în care doi specialişti, cu recunoaştere internaţională, discută despre managementul glaucomului și aderența pacienților la tratament.

                                      Vizionați webinarul:

Referințe:

1. 1. Marta Misiuk-Hojło, Pawłowska K. Preservatives in drops used in the treatment of glaucoma. Ophthatherapy. 2021;8(3):180-184. 2. Goldstein MH, Silva FQ, Blender N, Tran T, Vantipalli S. Ocular benzalkonium chloride exposure: problems and solutions. Eye (Lond). 2022;36(2):361-368. 3. Katz LJ, Cohen JS, Batoosingh AL, Felix C, Shu V, Schiffman RM. Twelve-month, randomized, controlled trial of bimatoprost 0.01%, 0.0125%, and 0.03% in patients with glaucoma or ocular hypertension. Am J Ophthalmol. 2010;149(4):661-671. 4. Goldberg I, Gil Pina R, Lanzagorta-Aresti A, Schiffman RM, Liu C, Bejanian M. Bimatoprost 0.03%/timolol 0.5% preservative-free ophthalmic solution versus bimatoprost 0.03%/timolol 0.5% ophthalmic solution (Ganfort) for glaucoma or ocular hypertension: a 12-week randomised controlled trial. Br J Ophthalmol. 2014;98(7):926-931. 5. Dietlein TS, Jordan JF, Lüke C, Schild A, Dinslage S, Krieglstein GK. Self-application of single-use eyedrop containers in an elderly population: comparisons with standard eyedrop bottle and with younger patients. Acta Ophthalmol. 2008 Dec;86(8):856-859. 6. Zhou X, Zhang X, Zhou D, Zhao Y, Duan X. A narrative review of ocular surface disease related to anti-glaucomatous medications. Ophthalmol Ther. 2022;11(5):1681-1704. 7. Eye drops – guidance on quantities to prescribe. NHS. March 13,2024. Available at: Available at: https://surreyccg.res-systems.net/PAD/Content/Documents/2/MCG%20eye%20drop%20supply%20information%20Oct %202018.pdf. Accessed on March 13, 2024. 8. European Glaucoma Society terminology and guidelines for glaucoma, 5th edition. Br J Ophthalmol. 2021;105(suppl 1):1-169.

RO-XALB-2024-00007